Assessing incremental value of biomarkers with multi-phase nested case-control studies

DOI10.1111/BIOM.12344MaRDI QIDQ2809548zbMATH OpenOpenAlexWikidataFDO

Authors Qian M. Zhou, Yingye Zheng, Lori B. Chibnik, Elizabeth W. Karlson, Tianxi Cai

Publication date 30 May 2016

Published in Biometrics (Search for Journal in Brave)

Full work available at URL http://europepmc.org/articles/pmc4819437

zbMATH Keywords

inverse probability weightingrisk predictionnested case-control studyincremental valuerheumatoid arthritistime dependent ROC curve analysis

Mathematics Subject Classification ID

Estimation in survival analysis and censored data (62N02) Applications of statistics to biology and medical sciences; meta analysis (62P10)

Recommendations

• Nonparametric Evaluation of Biomarker Accuracy Under Nested Case-Control Studies
• Evaluating the predictive value of biomarkers with stratified case-cohort design
• Evaluating prognostic accuracy of biomarkers in nested case-control studies
• Improving efficiency in biomarker incremental value evaluation under two-phase designs
• Robust risk prediction with biomarkers under two-phase stratified cohort design

Cites work

• A pseudolikelihood approach to analysis of nested case-control studies
• Asymptotic theory for nested case-control sampling in the Cox regression model
• Estimating the Error Rate of a Prediction Rule: Improvement on Cross-Validation
• Evaluating Prediction Rules fort-Year Survivors With Censored Regression Models
• Evaluating prognostic accuracy of biomarkers in nested case-control studies
• Nonparametric Evaluation of Biomarker Accuracy Under Nested Case-Control Studies
• Resampling procedures for making inference under nested case-control studies
• Retrospective studies and failure time models
• Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker
• Weighted analyses for cohort sampling designs

Cited in

(7)

• Nonparametric Evaluation of Biomarker Accuracy Under Nested Case-Control Studies
• Evaluating the predictive value of biomarkers with stratified case-cohort design
• New weighting methods when cases are only a subset of events in a nested case‐control study
• Nonparametric maximum likelihood estimators of time-dependent accuracy measures for survival outcome under two-stage sampling designs
• Statistical inference for net benefit measures in biomarker validation studies
• Incorporating monotonicity into the evaluation of a biomarker
• A semiparametric method for risk prediction using integrated electronic health record data

This page was built for publication: Assessing incremental value of biomarkers with multi-phase nested case-control studies

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2809548)